Aveanna Healthcare Holdings Inc. $AVAH Position Increased by Smith Group Asset Management LLC

Smith Group Asset Management LLC grew its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 34.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 263,669 shares of the company’s stock after purchasing an additional 67,393 shares during the period. Smith Group Asset Management LLC owned 0.12% of Aveanna Healthcare worth $1,698,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. raised its stake in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after acquiring an additional 1,535,351 shares during the period. Assenagon Asset Management S.A. lifted its holdings in Aveanna Healthcare by 16.4% in the first quarter. Assenagon Asset Management S.A. now owns 951,594 shares of the company’s stock worth $6,128,000 after acquiring an additional 134,043 shares during the last quarter. UBS Group AG boosted its stake in Aveanna Healthcare by 149.4% in the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock valued at $3,220,000 after acquiring an additional 236,152 shares during the period. Weiss Asset Management LP acquired a new position in Aveanna Healthcare in the first quarter valued at approximately $732,000. Finally, Precision Wealth Strategies LLC bought a new position in shares of Aveanna Healthcare during the fourth quarter valued at approximately $1,075,000. 87.96% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Truist Financial increased their price target on Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday, June 3rd. Barclays upped their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $10.78.

Insiders Place Their Bets

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 3,000,000 shares of the business’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the completion of the transaction, the insider owned 190,130 shares in the company, valued at approximately $1,522,941.30. The trade was a 94.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the transaction, the insider directly owned 10,112,123 shares of the company’s stock, valued at approximately $80,998,105.23. The trade was a 19.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 31,305,664 shares of company stock valued at $215,555,910 in the last quarter. 5.30% of the stock is owned by insiders.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $9.89 on Wednesday. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of 8.38, a price-to-earnings-growth ratio of 0.96 and a beta of 1.89. The company has a 50-day moving average price of $8.28 and a two-hundred day moving average price of $7.68.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. The company had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business’s revenue was up 15.9% compared to the same quarter last year. Analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.